Bhatt

Chen

Dalainas

Diener

ESPRIT Study Group

Goldstein

Hagberg

Jae-Kwan Cha

Kwon

Leira

Lovett

Markus

Mason

Myong-Jin Kang

Nomura

Norris

Patrignani

Pereira

Pulcinelli

Ross

Serebruany

Steinhubl

Su-Yun Lee

Wong

Yamasaki

Zambahari

English

PubMed

Crossref

Cilostazol Reduces PAC-1 Expression on Platelets in Ischemic Stroke

Antiplatelet agents in secondary prevention of stroke: a perspective.

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebocontrolled trial.

Aspirin or heparin in acute stroke.

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.

Aspirin resistance and atherothrombotic disease.

Aspirin resistance in cardiovascular disease: a review.

Atherosclerosis--an inflammatory disease.

Blood platelet activation evaluated by flow cytometry: optimised methods for clinical studies.

Can we predict early recurrence in acute stroke? Cerebrovasc Dis

Changes in platelet P-selectin and in plasma C-reactive protein in acute atherosclerotic ischemic stroke treated with a loading dose of clopidogrel.

Cilostazol in the management of vascular disease.

Cilostazol Prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis.

Clinical use of clopidogrel in acute coronary syndrome.

Current treatments in neurology: stroke.

Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies.

Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in patients after recent ischemic stroke: for the Plavix Use for Treatment of Stroke (PLUTO-Stroke) trial.

Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria.

Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40,000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups.

Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin.

Platelet-leukocyte interactions in inflammation and atherothrombosis. Semin Thromb Hemost

Rationale and protocol of a trial for prevention of diabetic atherosclerosis by using antiplatelet drugs: study of Diabetic Atherosclerosis Prevention by Cilostazol (DAPC study). Cardiovasc Diabetol

Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects.

The role of the platelet in the pathogenesis of atherothrombosis.

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2686855

Cilostazol Reduces PAC-1 Expression on Platelets in Ischemic Stroke

Abstract

Similar works

Full text

Available Versions

Crossref